Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:326 |
---|---|
Enthalten in: |
JAMA - 326(2021), 17 vom: 02. Nov., Seite 1661-1663 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rubin, Rita [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 17.11.2021 Date Revised 17.11.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1001/jama.2021.18143 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM331886952 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM331886952 | ||
003 | DE-627 | ||
005 | 20231225214448.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1001/jama.2021.18143 |2 doi | |
028 | 5 | 2 | |a pubmed24n1106.xml |
035 | |a (DE-627)NLM331886952 | ||
035 | |a (NLM)34647956 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rubin, Rita |e verfasserin |4 aut | |
245 | 1 | 0 | |a Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.11.2021 | ||
500 | |a Date Revised 17.11.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a News | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t JAMA |d 1948 |g 326(2021), 17 vom: 02. Nov., Seite 1661-1663 |w (DE-627)NLM000006939 |x 1538-3598 |7 nnns |
773 | 1 | 8 | |g volume:326 |g year:2021 |g number:17 |g day:02 |g month:11 |g pages:1661-1663 |
856 | 4 | 0 | |u http://dx.doi.org/10.1001/jama.2021.18143 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 326 |j 2021 |e 17 |b 02 |c 11 |h 1661-1663 |